Featured Companies

In Episode 12, Season 3 of the Amplifying Scientific Innovation Video Podcast, Dr. Sophia Ononye-Onyia, Founder and CEO of The Sophia Consulting Firm, interviewed Dr. Loddie Foose, Senior Director, Distributor and Emerging Markets, Seqirus and Founder and Global Lead, WIH Give Back, Healthcare Businesswomen’s Association (HBA).  Here, Dr. Foose shares personal anecdotes of her mission and results-driven leadership journey, industry outlook and her personal and professional commitment to volunteerism and philanthropy. For full transcript, please visit: https://sophiaconsultingfirm.com/blogs-and-articles/f/amplifying-scientific-innovation-dr-loddie-foose-seqirus-hba

In Episode 10, Season 3 of the Amplifying Scientific Innovation Video Podcast, Dr. Sophia Ononye-Onyia, Founder and CEO of The Sophia Consulting Firm, interviewed Dr. Mimi Huizinga, Head US Medical Oncology, Novartis, a leading global medicines company that is reimagining medicine to improve and extend people’s lives. Here, Dr. Huizinga shares personal anecdotes of her leadership journey, industry outlook and her focus on driving data, digital and health equity at Novartis. For full transcript, please visit: https://sophiaconsultingfirm.com/blogs-and-articles/f/amplifying-scientific-innovation-dr-mimi-huizinga-vp-novartis

In Episode 8, Season 3 of the Amplifying Scientific Innovation Video Podcast, Dr. Sophia Ononye-Onyia, Founder and CEO of The Sophia Consulting Firm, interviewed Ms. Sandra (Sandy) Amaro, Clinical Trial Diversity Operations Lead at Pfizer. Here, Ms. Amaro shares personal anecdotes of her leadership journey, industry outlook and her role in advancing clinical trial diversity at Pfizer, one of the world’s premier biopharmaceutical companies. For full transcript, please visit: https://sophiaconsultingfirm.com/blogs-and-articles/f/amplifying-scientific-innovation-sandra-amaro-trial-lead-pfizer.

In Episode 6, Season 3 of the Amplifying Scientific Innovation Video Podcast, Dr. Sophia Ononye-Onyia, Founder and CEO of The Sophia Consulting Firm, interviewed Ms. Kimberly Richardson, a seven year survivor of ovarian cancer who was recently diagnosed with triple-positive breast cancer. Ms. Richardson has served in prominent advocacy roles with organizations such as the Ovarian Cancer Research Alliance (OCRA) and most recently, she is supporting the development of the Survivors Advising Scientist Educational Program (SASEP). Here, Ms. Richardson shares the importance of data-enabled patients, diversity in clinical trials and the critical role that patient advocates play as living experts for the advancement of innovative therapies and diagnostic tools particularly in cancer research.

For full transcript, please visit: https://sophiaconsultingfirm.com/blogs-and-articles/f/amplifying-scientific-innovation-kim-richardson-cancer-patient

In Episode 4, Season 3 of the Amplifying Scientific Innovation Video Podcast, Dr. Sophia Ononye-Onyia, Founder and CEO of The Sophia Consulting Firm, interviewed Ms. Laurie Cooke, President and CEO of the Healthcare Businesswomen’s Association (HBA). Here, Ms. Cooke shares personal anecdotes of her leadership journey, industry outlook and her organization’s unique focus on furthering the advancement and impact of women in the business of healthcare. For full transcript, please visit: https://sophiaconsultingfirm.com/blogs-and-articles/f/amplifying-scientific-innovation-with-laurie-cooke-ceo-hba

Special panel edition of the Amplifying Scientific Innovation Video Podcast that will focus on innovative approaches for optimizing clinical trial diversity during the JP Morgan Healthcare Conference, which is the largest and most informative healthcare investment symposium in the industry. Moderated by Dr. Sophia Ononye-Onyia, Founder and CEO, The Sophia Consulting Firm. Panel lineup:  

• Mr. Bert Bruce is the Regional President, North America, Rare Disease at Pfizer, one of the world's premier biopharmaceutical companies. 
• Dr. Gary A. Puckrein is President and Chief Executive Officer of the National Minority Quality Forum (formerly the National Minority Health Month Foundation), a not-for-profit organization that he founded in 1998 with the goal of  strengthening the capacity of local communities to eliminate the disproportionate burden of premature death and preventable illness in minority populations. 
• Mr. Craig Lipset is an Advisor and Founder of Clinical Innovation Partners and former Head of Clinical Innovation at Pfizer.
• Ms. Janet Lynch Lambert is the CEO of the Alliance for Regenerative Medicine, the leading international advocacy organization dedicated to regenerative medicines and advanced therapies. 
• Dr. Mimi Huizinga is the VP and Head, US Oncology Medical at Novartis Oncology, a leading global medicines company that is reimagining medicine to improve and extend people’s lives.  

For full transcript, please visit: https://sophiaconsultingfirm.com/blogs-and-articles/f/amplifying-scientific-innovationclinical-trial-diversity-jpm-pt2